EMA validates submission of Marketing Authorization Application for skin cancer treatment Nidlegy: Sun Pharma, Philogen Ruchika Sharma5 July 2024 2:30 PM ISTMumbai: Sun Pharmaceutical Industries Limited and Philogen S.p.A. have announced that the European Medicines Agency (EMA) validated the...
Sun Pharma, Dr Reddy's Labs recall products in US over manufacturing issues Ruchika Sharma5 July 2024 12:18 PM ISTDr Reddy's Laboratories and Sun Pharma, two prominent pharmaceutical companies, are conducting recalls of products in the United States following...
Sun Pharma pulled up by USFDA for manufacturing issues at Dadra facility Ruchika Sharma4 July 2024 11:30 AM ISTMumbai: Sun Pharma did not sufficiently clean and maintain the equipment used in drug manufacturing at its manufacturing plant in Dadra,...
Sun Pharma unveils #SecondBirthDate 2.0 Initiative with Sushmita Sen on National Doctors' Day Ruchika Sharma1 July 2024 1:26 PM ISTMumbai: Continuing its inspiring, award-winning initiative to celebrate and honour the invaluable contributions of doctors in our lives, Sun...
Taro Pharma now wholly owned by Sun Pharma Ruchika Sharma24 Jun 2024 5:23 PM ISTMumbai: Sun Pharmaceutical Industries Limited today announced the successful completion of the merger of Taro Pharmaceutical Industries Ltd....
USFDA issues warning letter to Sun Pharma Dadra facility Ruchika Sharma20 Jun 2024 12:34 PM ISTMumbai: Sun Pharmaceutical Industries Limited has received a Warning Letter from the US Food and Drug Administration (USFDA) for its Dadra...
Sun Pharma, Moebius Medical present positive data from phase 2b trial of MM-II in painful knee osteoarthritis patients at EULAR 2024 Ruchika Sharma15 Jun 2024 12:30 PM ISTSun Pharma and Moebius Medical, who have been jointly developing MM-II, have announced plans to initiate a Phase 3 clinical program.
Sun Pharma, Philogen seek EMA marketing nod for skin cancer treatment Nidlegy Ruchika Sharma4 Jun 2024 4:45 PM ISTMumbai: Philogen S.p.A. and Sun Pharmaceutical Industries Limited have announced the submission of a Marketing Authorization Application (MAA)...
Incorporate sample size proportionate with each indication: CDSCO Panel Tells Sun Pharma on Ranibizumab study Dr. Divya Colin3 Jun 2024 6:00 PM ISTNew Delhi: Reviewing the proposal for conducting the Phase IV study of Ranibizumab Solution for Injection 10 mg/mL, the Subject Expert Committee (SEC)...
Sun Pharma anticipates high single-digit top line growth in current fiscal: Dilip Shanghvi Ruchika Sharma3 Jun 2024 11:53 AM ISTNew Delhi: Sun Pharmaceutical Industries, a leading pharmaceutical company, anticipates achieving a robust single-digit top line increase in...
Results of Phase III PIVOTAL trial of Nidlegy in melanoma to be presented at ASCO 2024 Ruchika Sharma1 Jun 2024 11:30 AM ISTMumbai: Philogen S.p.A. and Sun Pharmaceutical Industries Limited have announced that the primary results of the Nidlegy Phase III PIVOTAL...
Conduct BE study: CDSCO Panel Tells Sun Pharma Labs on COPD drug Umeclidinium powder for inhalation Dr. Divya Colin31 May 2024 6:00 PM ISTNew Delhi: In line with the proposal to manufacture and market Umeclidinium powder for inhalation 62.5mcg, the Subject Expert Committee (SEC)...
